BD HealthSight™ Diversion Management leverages advanced analytics and machine learning to bring visibility across the entire medication-use process. As part of BD’s HealthSight™ Enterprise Pharmacy Analytics platform, the solution connects data from medication dispensing systems, inventory management tools, and the electronic medical record (EMR) to identify patterns that may indicate diversion—helping pharmacy leaders move from reactive investigations to proactive detection.
The platform analyzes clinician behavior against dynamically selected peer groups, generating risk scores and highlighting anomalies that may warrant further review. This approach enables pharmacies to detect potential diversion earlier, rather than relying on time-intensive manual reconciliation processes that can take months or longer. BD HealthSight™ also automates controlled substance reconciliation and flags discrepancies in real time, allowing teams to focus investigative efforts where they are most needed. Integrated dashboards and workflows support case management, helping organizations monitor, triage, and document investigations more efficiently while maintaining compliance.
Key Capabilities of BD HealthSight™ Diversion Management:
- Machine learning analytics to identify anomalous clinician behavior
- Automated controlled substance reconciliation and discrepancy detection
- Integration with EMR and pharmacy systems for end-to-end visibility
- Risk scoring and peer comparison to support targeted investigations
- Workflow tools for case management, documentation, and compliance tracking
